Location History:
- Kanagawa, JP (2010 - 2016)
- Kamakura, JP (2015 - 2023)
Company Filing History:
7 out of 3,476 
3 out of 222 
2 out of 815 
Years Active: 2010-2023
Title: Giman Jung: Innovator in Pancreatic and Biliary Tract Cancer Detection
Introduction
Giman Jung is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of pancreatic dysfunction and biliary tract cancer. With a total of 7 patents to his name, Jung's work is characterized by its focus on innovative and minimally invasive methods.
Latest Patents
One of Jung's latest patents is a method and kit for the detection of pancreatic dysfunction. This invention aims to provide a simple and highly accurate method for detecting pancreatic exocrine dysfunction with minimal invasiveness to a subject. The method involves in vitro measurement of two APOA2 protein variants, mutants thereof, and/or fragments thereof in a body fluid sample derived from the subject. The presence or absence of pancreatic exocrine dysfunction is determined based on the measured amounts, and the detection kit includes antibodies that can specifically bind to these proteins.
Another significant patent by Jung is a method and kit for the detection of biliary tract cancer. This invention provides a method for detecting biliary tract cancer by measuring the amounts of APOA2 protein variants in a test sample using anti-APOA2 antibodies. The detection kit for biliary tract cancer includes these antibodies, enhancing the accuracy of cancer detection.
Career Highlights
Throughout his career, Giman Jung has worked with prominent organizations such as Toray Industries, Inc. and the National Cancer Center. His experience in these institutions has allowed him to develop and refine his innovative diagnostic methods.
Collaborations
Jung has collaborated with notable colleagues, including Michimoto Kobayashi and Satoko Kanamori, who have contributed to his research and development efforts.
Conclusion
Giman Jung's contributions to medical diagnostics, particularly in the detection of pancreatic dysfunction and biliary tract cancer, highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to developing methods that are both effective and minimally invasive, showcasing the potential for significant advancements in medical technology.